Current Price Status
Stock is Under Pressure
Market is pricing a weaker earning growth potential than the industry average.
Undervalued stock can be true bargain buy if the stock is believed to be only under pressured for a short-term weak earning growth.
Company is in Positive Earning
- KOTRA current price is 31.08% below OneDelta estimated fair value.
The fair value is estimated via OneDelta proprietary model that updated daily basis based on stock fundamental and specific industry relative marco outlook. It can be assessed as stock potential upside range or the stock true value price in case of downside.
Relative Price Performance
UnderperformedKOTRA past 5-day return lagged behind the Pharmaceuticals industry average return by 4.97%
Below 30-Day AverageCurrent price RM2.51 is below 30-day average RM2.55 by 1.6%
Bank Analyst Price Targets
Revenue & Earning Growth Analysis
Cyclical Revenue Growth
KOTRA recorded various revenue growth in different quarters with no clear growth direction.
Unstable Profit Growth
KOTRA has been experiencing substantial ups and downs on profit growth.
Past Quarter Reports
|Quarter Date||Revenue (RM)||(%)||EPS (RM)||(%)|
Volume Trend Analysis
Recent Volume is Decreasing
Decreasing trading volume tends to keep stock price range bound in near term.
Low Volume/Liquidity Stock
Only RM6k worth of stock was traded for this stock past month. Low liquidity stock is danger for price manipulation and more difficult to sell at market price.
KOTRA recent daily traded volume is NAN% lower than past month average.
|Past 30-Day||Past 5-Day|
|0k daily||0k daily|
Price History Chart
Past 30-day Average Price: RM2.55
Stock Fundamental Factors
Fundamental factor characteristics help us understand and expect how the stock price will behave in short and long term.
Stock Thematic Baskets
Usually the more the stock is included in popular themes, the more opportunity for price-driven momentum and better liquidity.
Market News & Investor Opinions
Stock Company Profile
KOTRA INDUSTRIES BHD
Kotra Industries Bhd. is an investment holding company, which engages in the development, manufacture, and trade of pharmaceutical and healthcare products. It operates through the Local and Export segments. It distributes its products under the following brands: Appeton, Axcel, and Vaxcel. The company was founded on September 15, 1982 and is headquartered in Melaka, Malaysia.